<DOC>
	<DOC>NCT02416869</DOC>
	<brief_summary>The aim of this randomized double-blind cross over clinical trial is to investigate effectiveness of different routes of applications (intramuscular and submucous at the site of surgery) and doses (4 mg and 8 mg) of Dexamethasone on swelling, trismus, pain and quality of life after lower third molar surgery.</brief_summary>
	<brief_title>Dexamethasone in Lower Third Molar Surgery</brief_title>
	<detailed_description />
	<mesh_term>Tooth, Impacted</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Healthy patients (ASA I) Bilateral symmetrically impacted lower third molars according to PelGregory's and Winter's classification Heavy tobacco smokers Drug and / or alcohol abusers</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Dexamethasone</keyword>
	<keyword>Lower third molar surgery</keyword>
</DOC>